This study is looking at a new medication that is biosimilar (has similar properties to an existing drug) to Adalimumab (Humira®). The purpose of this study is to assess how the study medication effects the immune system and how the body processes the study drug in comparison to Adalimumab (Humira®), sourced from North America and Europe. The investigational medication has not been approved for marketing by any government agencies but Adalimumab (Humira®) is approved for the treatment of various conditions such as various types of arthritis in Australia, the US and other countries.
We are seeking healthy participants for this study, please click below to register your interest.
Please note – you only need to register with us once, if you are interested in multiple studies, please just fill in one registration form and give us a call or email email@example.com to let us know which studies you are interested in.